Skip to Content
Merck
  • Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.

Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.

Anticancer research (2000-01-11)
H Aikawa, H Takahashi, S Fujimura, M Sato, C Endo, A Sakurada, T Kondo, T Tanita, Y Matsumura, S Ono, Y Saito, M Sagawa
ABSTRACT

In order to elucidate the roles of tumor angiogenesis in lung carcinogenesis, the expressions of several angiogenic factors in lung carcinoma tissues were examined. Tissue specimens from 112 cases of resected non-small cell lung cancer (NSCLC) were studied. The expressions of platelet-derived endothelial cell growth factor (PD-ECGF) and vascular endothelial growth factor (VEGF) were examined immunohistochemically. Microvessel density (MVD) was also evaluated. VEGF-positive cases were observed more frequently in advanced stage lung cancers than in early cancers, and VEGF-positive tumors had higher MVD than VEGF-negative tumors, while such differences were not observed for PD-ECGF. In squamous cell carcinoma, the patients with high-MVD tumor had significantly worse survival than those with low-MVD tumor. Our results suggest that VEGF plays an important role in angiogenesis of lung cancers, while the contribution of PD-ECGF may be limited.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Platelet-Derived Endothelial Cell Growth Factor human, recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder, suitable for cell culture